Should You Buy Pfizer Stock Before Nov. 4?

Key Points Pfizer's stock has been trading at low levels for a while. Diminished growth and concerns about the future have investors thinking twice about the stock. The company did show signs of progress in its previous quarterly report. 10 stocks we like better than Pfizer › One struggling pharma stock that could use a boost from a strong earnings report is Pfizer (NYSE: PFE). The company's valuation has plummeted in recent years as patent cliffs and question marks about its long-term growth ha ...